title: Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats.
abstract: Social deprivation in early life disrupts emotionality and attentional processes in humans. Rearing rats in isolation reproduces some of these abnormalities, which are attenuated by daily handling. However, the neurochemical mechanisms underlying these responses remain poorly understood. We hypothesized that post-weaning social isolation alters the endocannabinoid system, a neuromodulatory system that controls emotional responding. We characterized behavioral consequences of social isolation and evaluated whether handling would reverse social isolation-induced alterations in behavioral reactivity to context and the endocannabinoid system. At weaning, pups were single or group housed and concomitantly handled or not handled daily until adulthood. Rats were tested in emotionality- and attentional-sensitive behavioral assays (open field, elevated plus maze, startle and prepulse inhibition). Cannabinoid receptor densities and endocannabinoid levels were quantified in a separate group of rats. Social isolation negatively altered behavioral responding. Socially-isolated rats that were handled showed less deficits in the open field, elevated plus maze, and prepulse inhibition tests. Social isolation produced site-specific alterations (supraoptic nucleus, ventrolateral thalamus, rostral striatum) in cannabinoid receptor densities compared to group rearing. Handling altered the endocannabinoid system in neural circuitry controlling emotional expression. Handling altered endocannabinoid content (prefrontal and piriform cortices, nucleus accumbens) and cannabinoid receptor densities (lateral globus pallidus, cingulate and piriform cortices, hippocampus) in a region-specific manner. Some effects of social isolation on the endocannabinoid system were moderated by handling. Isolates were unresponsive to handling-induced increases in cannabinoid receptor densities (caudal striatum, anterior thalamus), but were sensitive to handling-induced changes in endocannabinoid content (piriform, prefrontal cortices), compared to group-reared rats. Our findings suggest alterations in the endocannabinoid system may contribute to the abnormal isolate phenotype. Handling modifies the endocannabinoid system and behavioral reactivity to context, but surmounts only some effects of social isolation. These data implicate a pivotal role for the endocannabinoid system in stress adaptation and emotionality-related disturbances.
authors.affiliation: Neuroscience and Behavior Program, Department of Psychology, University of Georgia, Athens, GA 30622, USA.
authors.forename: N R
authors.initials: NR
authors.lastname: Sciolino
authors.forename: M
authors.initials: M
authors.lastname: Bortolato
authors.forename: S A
authors.initials: SA
authors.lastname: Eisenstein
authors.forename: J
authors.initials: J
authors.lastname: Fu
authors.forename: F
authors.initials: F
authors.lastname: Oveisi
authors.forename: A G
authors.initials: AG
authors.lastname: Hohmann
authors.forename: D
authors.initials: D
authors.lastname: Piomelli
mesh_terms: D000818:Animals; D001288:Attention; D001522:Behavior, Animal; D001921:Brain / Q000378:metabolism; D063385:Cannabinoid Receptor Modulators / Q000502:physiology*; D004644:Emotions; D063388:Endocannabinoids; D005260:Female; D006234:Handling, Psychological; D008297:Male; D018782:Maze Learning; D051381:Rats; D017207:Rats, Sprague-Dawley; D043882:Receptors, Cannabinoid / Q000378:metabolism; D013216:Reflex, Startle; D015398:Signal Transduction; D012934:Social Isolation
chemical_list: D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D043882:Receptors, Cannabinoid
references.citation: J Neurosci. 2009 Aug 12;29(32):9955-60
references.pmid: 19675229
references.citation: J Neurosci. 2002 Sep 15;22(18):7840-3
references.pmid: 12223535
references.citation: J Neural Transm (Vienna). 2008 Dec;115(12):1673-9
references.pmid: 18974922
references.citation: J Neurosci. 1999 Aug 15;19(16):6795-805
references.pmid: 10436037
references.citation: Methods Find Exp Clin Pharmacol. 1984 Aug;6(8):433-6
references.pmid: 6541736
references.citation: Neurosci Lett. 1992 Mar 30;137(2):185-8
references.pmid: 1584459
references.citation: Synapse. 2000 Jul;37(1):71-80
references.pmid: 10842353
references.citation: Eur J Neurosci. 2005 Feb;21(4):1057-69
references.pmid: 15787710
references.citation: Neuropharmacology. 2008 Jan;54(1):108-16
references.pmid: 17675104
references.citation: Trends Pharmacol Sci. 2008 Oct;29(10):493-8
references.pmid: 18755516
references.citation: Chem Phys Lipids. 2002 Dec 31;121(1-2):173-90
references.pmid: 12505699
references.citation: J Neurosci. 2006 Mar 15;26(11):2991-3001
references.pmid: 16540577
references.citation: Physiol Behav. 1988;43(1):13-6
references.pmid: 3413245
references.citation: Acta Psychiatr Scand. 2008 Jun;117(6):420-31
references.pmid: 18479318
references.citation: Psychopharmacology (Berl). 2004 Jan;171(2):148-55
references.pmid: 13680076
references.citation: Nat Med. 2008 Sep;14(9):923-30
references.pmid: 18776886
references.citation: Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
references.pmid: 10817843
references.citation: Mol Neurobiol. 2009 Jun;39(3):178-84
references.pmid: 19267225
references.citation: Nature. 2005 Jun 23;435(7045):1108-12
references.pmid: 15973410
references.citation: Mol Pharmacol. 2007 Dec;72(6):1557-66
references.pmid: 17895407
references.citation: Biol Psychiatry. 1993 Sep 15;34(6):361-72
references.pmid: 8218603
references.citation: Behav Brain Res. 1982 Sep;6(1):93-100
references.pmid: 7126327
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6370-5
references.pmid: 11959912
references.citation: Neuroscience. 2009 Mar 3;159(1):21-30
references.pmid: 19141315
references.citation: Psychopharmacology (Berl). 2008 Oct;200(3):333-46
references.pmid: 18545985
references.citation: Dev Psychobiol. 2009 May;51(4):333-44
references.pmid: 19308959
references.citation: Exp Neurol. 2003 Oct;183(2):600-9
references.pmid: 14552901
references.citation: Brain Res. 1999 Apr 10;824(2):197-203
references.pmid: 10196449
references.citation: Int J Neuropsychopharmacol. 2009 Jun;12(5):599-614
references.pmid: 18789179
references.citation: Lipids Health Dis. 2003 Aug 19;2:5
references.pmid: 12969514
references.citation: Neurosci Biobehav Rev. 2009 Sep;33(8):1157-67
references.pmid: 19747594
references.citation: Neuropharmacology. 2008 Dec;55(8):1397-404
references.pmid: 18809420
references.citation: Neuropsychopharmacology. 2007 Oct;32(10):2098-107
references.pmid: 17299506
references.citation: Neuropsychopharmacology. 2005 Mar;30(3):508-15
references.pmid: 15525997
references.citation: Biol Psychiatry. 2000 May 15;47(10):864-73
references.pmid: 10807959
references.citation: Neuroendocrinology. 2010;91(2):155-68
references.pmid: 19815998
references.citation: J Neurosci. 1999 Jun 1;19(11):4544-58
references.pmid: 10341254
references.citation: J Neurosci Res. 2005 Oct 15;82(2):264-72
references.pmid: 16175569
references.citation: J Comp Neurol. 2000 Jun 26;422(2):159-71
references.pmid: 10842224
references.citation: Dev Psychobiol. 1977 Mar;10(2):123-32
references.pmid: 838157
references.citation: J Physiol. 2005 Dec 1;569(Pt 2):501-17
references.pmid: 16179366
references.citation: Biol Psychiatry. 2005 Jun 15;57(12):1550-8
references.pmid: 15953492
references.citation: J Neurosci Methods. 1985 Aug;14(3):149-67
references.pmid: 2864480
references.citation: Synapse. 2009 Nov;63(11):941-50
references.pmid: 19593824
references.citation: J Neurosci Methods. 1980 Dec;3(2):129-49
references.pmid: 6110810
references.citation: Neurosci Behav Physiol. 2003 Jan;33(1):13-29
references.pmid: 12617300
references.citation: Psychopharmacology (Berl). 1999 Jun;144(4):311-5
references.pmid: 10435402
references.citation: Psychopharmacology (Berl). 2008 May;198(1):29-36
references.pmid: 18084745
references.citation: Neuropsychopharmacology. 2006 Dec;31(12):2591-9
references.pmid: 16710317
references.citation: Behav Brain Res. 1997 Dec;89(1-2):35-49
references.pmid: 9475613
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2005 May;371(5):428-33
references.pmid: 15995876
references.citation: Neuroscience. 2010 Apr 14;166(4):1036-42
references.pmid: 20096332
references.citation: Int J Neuropsychopharmacol. 2007 Dec;10(6):727-39
references.pmid: 17076936
references.citation: J Neurosci. 2008 Jul 16;28(29):7284-92
references.pmid: 18632932
references.citation: J Neurochem. 2002 Feb;80(3):448-56
references.pmid: 11905991
references.citation: Int J Neuropsychopharmacol. 2010 Apr;13(3):373-86
references.pmid: 19607756
references.citation: Eur J Neurosci. 2009 May;29(10):1964-78
references.pmid: 19453631
references.citation: Neuropsychopharmacology. 2004 Nov;29(11):2108-14
references.pmid: 15354183
references.citation: Psychopharmacology (Berl). 1998 Oct;139(3):203-9
references.pmid: 9784074
references.citation: Neuron. 2001 Mar;29(3):729-38
references.pmid: 11301031
references.citation: Eur J Pharmacol. 1980 Aug 8;65(4):463-4
references.pmid: 7408954
references.citation: Prog Brain Res. 2008;170:129-36
references.pmid: 18655878
references.citation: Pharmacol Biochem Behav. 2002 Aug;73(1):7-17
references.pmid: 12076720
references.citation: Physiol Behav. 2000 Jan;68(3):389-94
references.pmid: 10716550
references.citation: Psychiatry Res. 1991 Mar;36(3):307-17
references.pmid: 1829534
references.citation: Curr Opin Pharmacol. 2009 Feb;9(1):46-52
references.pmid: 19157983
references.citation: Neurosci Biobehav Rev. 2008 Aug;32(6):1087-102
references.pmid: 18423591
references.citation: Pharmacol Biochem Behav. 1996 May;54(1):21-30
references.pmid: 8728535
references.citation: Neurobiol Dis. 2008 Aug;31(2):159-68
references.pmid: 18585920
references.citation: Clin Exp Pharmacol Physiol. 2003 Apr;30(4):254-61
references.pmid: 12680843
references.citation: Exp Brain Res. 2006 Jul;172(4):556-60
references.pmid: 16710682
references.citation: Physiol Behav. 1997 Aug;62(2):291-7
references.pmid: 9251970
references.citation: Dev Psychopathol. 2005 Spring;17(2):271-301
references.pmid: 16761546
references.citation: Neurosci Lett. 1998 Aug 7;252(1):13-6
references.pmid: 9756347
references.citation: J Comp Neurol. 1977 Mar 15;172(2):247-63
references.pmid: 838881
references.citation: Psychopharmacology (Berl). 2000 Jul;151(1):55-63
references.pmid: 10958117
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):355-60
references.pmid: 14751433
references.citation: Behav Neurosci. 2008 Aug;122(4):849-54
references.pmid: 18729638
references.citation: Psychopharmacology (Berl). 2003 Jan;165(2):128-35
references.pmid: 12404071
references.citation: Brain Res Mol Brain Res. 1993 May;18(3):195-200
references.pmid: 8497182
references.citation: Biol Psychiatry. 2007 Apr 1;61(7):865-72
references.pmid: 17125743
references.citation: Physiol Behav. 1999 Sep;67(3):385-92
references.pmid: 10497957
references.citation: J Neurochem. 2008 Jan;104(1):233-43
references.pmid: 17944864
references.citation: Neurosci Bull. 2007 Nov;23(6):341-7
references.pmid: 18064064
references.citation: Arch Gen Psychiatry. 2000 Aug;57(8):761-8
references.pmid: 10920464
references.citation: J Neurosci. 1991 Feb;11(2):563-83
references.pmid: 1992016
references.citation: Neuroreport. 1999 Jun 3;10(8):1665-9
references.pmid: 10501554
references.citation: Psychopharmacology (Berl). 2009 Jul;204(4):607-16
references.pmid: 19259645
references.citation: Immunobiology. 2010 Aug;215(8):629-46
references.pmid: 19616342
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8104-9
references.pmid: 10884434
references.citation: Behav Brain Res. 1999 Apr;100(1-2):177-83
references.pmid: 10212065
references.citation: Physiol Behav. 2002 Sep;77(1):55-64
references.pmid: 12213502
references.citation: Physiol Behav. 1982 Jan;28(1):117-24
references.pmid: 7079310
references.citation: Aust N Z J Psychiatry. 2008 May;42(5):357-68
references.pmid: 18473254
references.citation: Behav Brain Res. 1994 Apr 18;61(2):169-73
references.pmid: 8037864
references.citation: Pharmacol Biochem Behav. 2004 Apr;77(4):839-45
references.pmid: 15099930
references.citation: Addict Biol. 2008 Jun;13(2):264-75
references.pmid: 18482435
references.citation: Behav Brain Res. 2001 May;120(2):221-4
references.pmid: 11182170
references.citation: Mol Cell Neurosci. 2000 Jun;15(6):510-21
references.pmid: 10860578
references.citation: Brain Res. 2007 Apr 13;1141:37-47
references.pmid: 17300761
references.citation: Neuroscience. 2008 Mar 3;152(1):265-72
references.pmid: 18082330
references.citation: Neuroscience. 2002;110(4):755-64
references.pmid: 11934482
references.citation: Neuropharmacology. 2008 Dec;55(7):1183-90
references.pmid: 18708079
references.citation: Neuropharmacology. 2009;56 Suppl 1:226-34
references.pmid: 18691604
references.citation: Neuropharmacology. 2008 Apr;54(5):815-23
references.pmid: 18262573
references.citation: Eur J Pharmacol. 1990 Nov 20;191(1):111-4
references.pmid: 2092998
references.citation: Neuroscience. 2001;103(1):9-15
references.pmid: 11311783
references.citation: J Neurosci. 2003 Aug 13;23(19):7281-7
references.pmid: 12917361
references.citation: Psychopharmacology (Berl). 2004 Sep;175(2):220-4
references.pmid: 15088080
references.citation: Hippocampus. 2009 Jul;19(7):623-32
references.pmid: 19115376
references.citation: J Neurosci. 2006 May 24;26(21):5628-37
references.pmid: 16723519
references.citation: Brain Res. 2003 Sep 5;983(1-2):128-36
references.pmid: 12914973
references.citation: Synapse. 2009 Jun;63(6):476-83
references.pmid: 19217027
references.citation: Behav Brain Res. 1996 Feb;75(1-2):27-32
references.pmid: 8800657
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 15;877(26):2755-67
references.pmid: 19171504
references.citation: Arch Gen Psychiatry. 2000 Jul;57(7):637-48
references.pmid: 10891034
references.citation: Braz J Med Biol Res. 2005 Nov;38(11):1691-6
references.pmid: 16258640
references.citation: Int J Neuropsychopharmacol. 2007 Oct;10(5):595-607
references.pmid: 17134528
references.citation: Brain Res. 1999 Mar 20;822(1-2):17-25
references.pmid: 10082879
references.citation: Eur J Neurosci. 2006 Jun;23(12):3319-27
references.pmid: 16820021
references.citation: Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):371-82
references.pmid: 19588184